Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 13,580 shares at $35.06 ($453K) on 2021-09-23, disclosed to the SEC on 2021-09-27.
Scheduled sale ($453k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.06 | 200 | $7K | 1.5% |
| 2 | $33.31 | 9,747 | $325K | 71.7% |
| 3 | $33.31 | 3,633 | $121K | 26.7% |
| Total | $33.34 avg | 13,580 | $453K | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |
| MYGN | SELL | 2021-07-12 | $3.3M | — | Filing → |